Forget Dodgy Ruses: Solid Shares Offer Solid Returns

For long-term wealth creation, it has to be the stock market.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

You’ve quite possibly seen an article — first published in The Daily Telegraph — arguing that it was possible to earn 6.8% on this year’s Cash ISA allowance. It’s all down to adroit selection of accounts, plus taking advantage of special enhanced interest rate offers.

And on the face of it, the idea of a 6.8% income with no risk to your capital doesn’t look too bad.

But hang on. Not only are those returns not what they seem, it’s perfectly possible to do a lot better, by investing in the stock market.

How? Adroit selection certainly plays a part — this time, in cleverly selecting low-risk shares and investment funds. But so too does sitting back, patiently taking a long-term view, and waiting for the stock market to work its wealth-building magic. It’s worked for Warren Buffett.

Smoke and mirrors

First, though, let’s look a little more closely at those Telegraph numbers.

To start with, £160 of the £390 claimed “income” comes in marketing kickbacks from holding a single Halifax current account — including a whopping £100 as a reward just for opening it. The rest? Delivered through enhanced rates of interest on capped accounts, and heroically cycling money through bank accounts in a way that would impress even Bernie Madoff.

A sustainable source of income? Hardly.

Nor does it “scale up” for higher investment amounts: you get that same £100 for opening the account, no matter how much you hold within the three interest‑earning accounts that the article mentions. And the Nationwide and TSB accounts that the Telegraph is suggesting are capped at £2,500 and £2,000 respectively — put any more in, and you won’t get the enhanced rates of interest on offer.

So while you can certainly get 6.8% on £5,760, my estimates show that the return falls to 4.4% on an investment twice that £5,760, and to just 2.9% on three times that much.

Take a stake in solid businesses

So what is an investor to do?

Well, I’ve news for you. The Motley Fool has always believed that serious investors prepared to take a long‑term view can build a decent income — and get some handy capital growth — through building a stake in some of Britain’s biggest and best businesses.

On today’s prices, for instance, GlaxoSmithKline offers a full-year forecast yield of 5.3%. HSBC is yielding 5.8%. And Royal Dutch Shell is yielding 5.1%. Even juicier, thanks to Ed Miliband’s sabre-rattling over energy prices, electricity giant SSE — which possesses one of the FTSE’s finest dividend records — is yielding a whopping 6%.

Spread your money across such shares, in short, throw in a little by way of capital gains, and that 6.8% soon looks paltry. Better still, such dividend stalwarts are good for the long term, holding out the prospect of steadily rising dividends, plus incremental capital growth. As a strategy, it’s served Warren Buffett very well.

Leave it to the experts

Of course, not every investor feels comfortable with holding just a few shares — especially if they’re new to the stock market, and more accustomed to Cash ISAs as investment vehicles.

In which case, so-called equity income funds are an option to consider. Run by professional fund managers and investment banks, equity income funds aim to deliver a high-and-growing income by investing in a broad selection of shares, mostly within the UK, but also overseas.

Again, the yields on offer aren’t to be sniffed at. Artemis Income, for instance, yields 3.7%, and holds several of the shares listed above, plus companies such as Rio Tinto, BP, Legal & General and AstraZeneca. Threadneedle UK Equity Income holds a broadly comparable clutch of shares, and delivers 3.3%. Rathbone Income, another similar offering, yields 3.53%.

Like the idea, but don’t want to pay fund managers’ fees — not to mention platform fees payable to a fund supermarket such as Hargreaves Lansdown or AJ Bell Youinvest? In that case, a premium share-tipping service, targeted on selecting solid income picks, could be the way forward.

Cash is for the birds

Roll it all together, in short, and the Telegraph’s 6.8% doesn’t seem so attractive. For my money, investing in solid businesses through shares and funds offers a better prospect of a decent income and the prospect of capital growth.

Certainly better than that offered by cash — for as studies repeatedly show, not only do shares comfortably outperform bonds and cash over the long term, but at present the real inflation-adjusted return on cash is close to zero.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Malcolm holds GlaxoSmithKline, Royal Dutch Shell, SSE, BP and AstraZeneca. The Motley Fool has recommended shares in GlaxoSmithKline.

More on Investing Articles

Number three written on white chat bubble on blue background
Investing Articles

Just released: the 3 best growth-focused stocks to consider buying in May [PREMIUM PICKS]

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

With £1,000 to invest, should I buy growth stocks or income shares?

Dividend shares are a great source of passive income, but how close to retirement, should investors think about shifting away…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Warren Buffett should buy this flagging FTSE 100 firm!

After giving $50bn to charity, Warren Buffett still has a $132bn fortune. Also, his company has $168bn to spend, so…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing For Beginners

I wish I’d known about this lucrative style of stock market investing 20 years ago

Research has shown that over the long term, this style of investing can generate returns in excess of those provided…

Read more »

Woman using laptop and working from home
Investing Articles

Is this growing UK fintech one of the best shares to buy now?

With revenues growing at 24% and income growing at 36%, Wise looks like one of the best shares to buy…

Read more »

Dividend Shares

Are Aviva shares one of the UK’s best investments today?

UK investors have been piling into Aviva shares recently. However, Edward Sheldon's wondering if he could get bigger returns elsewhere.

Read more »

Older couple walking in park
Investing Articles

10.2% dividend yield! 2 value shares to consider for a £1,530 passive income

Royston Wild explains why investing in these value shares could provide investors with significant passive income for years to come.

Read more »

man in shirt using computer and smiling while working in the office
Investing Articles

Nvidia and a FTSE 100 fund own a 10% stake in this $8 artificial intelligence (AI) stock

Ben McPoland explores Recursion Pharmaceuticals (NASDAQ:RXRX), an up-and-coming AI firm held by Cathie Wood, Nvidia and one FTSE 100 trust.

Read more »